Perinatal propionate supplementation prevented offspring hypertension, accompanied by shaping gut microbiota with increases in species richness and evenness, increasing the plasma propionate level and upregulating the renal GPR41 expression. This evidence concerns the gene FFAR3 and hypertensive disorder.